Compare ONTF & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ONTF | CADL |
|---|---|---|
| Founded | 1998 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 347.2M | 357.4M |
| IPO Year | 2021 | 2021 |
| Metric | ONTF | CADL |
|---|---|---|
| Price | $8.11 | $5.00 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | $8.10 | ★ $19.71 |
| AVG Volume (30 Days) | 599.1K | ★ 1.2M |
| Earning Date | 05-06-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 32.67 | ★ 58.62 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $139,312,000.00 | $125,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.51 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.35 | $4.25 |
| 52 Week High | $8.11 | $7.24 |
| Indicator | ONTF | CADL |
|---|---|---|
| Relative Strength Index (RSI) | 67.87 | 48.99 |
| Support Level | $7.84 | $4.58 |
| Resistance Level | N/A | $5.42 |
| Average True Range (ATR) | 0.02 | 0.26 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 88.89 | 68.62 |
ON24 Inc provides a cloud-based intelligent engagement platform that combines experiences with personalization and content, to enable sales and marketing organizations to capture and act on connected insights at scale. The company's platform offers a portfolio of interactive and hyper-personalized digital experience products that create and capture actionable, real-time data at scale from millions of professionals to provide businesses with buying signals and behavioral insights to efficiently convert prospects into customers. It provides solutions to Financial services, Life Sciences, Life sciences, Insurance, Technology, Associations, and Others. Geographically, the company derives maximum revenue from United States, and also has its presence in EMEA and Other Countries.
Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.